BALYASNY ASSET MANAGEMENT L.P. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$189,170
-99.0%
11,920
-98.8%
0.00%
-100.0%
Q2 2023$19,484,766
+4838.3%
1,032,579
+904.9%
0.04%
+4200.0%
Q1 2023$394,564
-79.4%
102,751
-73.4%
0.00%
-80.0%
Q4 2022$1,918,498
+289.1%
386,794
+252.5%
0.01%
+150.0%
Q2 2022$493,000
-61.0%
109,741
-42.8%
0.00%
-66.7%
Q2 2021$1,264,000
+8.4%
191,876
-55.4%
0.01%
-25.0%
Q1 2019$1,166,000
-4.0%
430,328
+70.0%
0.01%
-11.1%
Q4 2018$1,215,000
-91.2%
253,085
-80.8%
0.01%
-84.5%
Q1 2018$13,866,000
+8566.2%
1,318,023
+5176.7%
0.06%
Q4 2017$160,000
+135.3%
24,978
+12.4%
0.00%
Q2 2016$68,00022,2220.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders